Iloprost Waymade

Iloprost, the active ingredient in Iloprost Waymade, is a prostacyclin analog presented as an injection solution for intravenous use. It treats pulmonary arterial hypertension and digital ulcers associated with systemic sclerosis.\n\nGNH India supplies Iloprost Waymade as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Iloprost acts on the prostacyclin pathway to provide vasodilation and anti‑platelet effects in specific vascular disorders.\n\nPulmonary arterial hypertension: improves exercise capacity and lowers pulmonary vascular resistance.\nDigital ulcers associated with systemic sclerosis: promotes ulcer healing and reduces formation of new ulcers.

Iloprost may cause a range of adverse reactions that vary in frequency and severity.\n\nCommon Side Effects:\n- Flushing or warmth sensation\n- Headache\n- Nausea or vomiting\n- Jaw or tooth pain\n- Hypotension during infusion\n- Infusion‑site pain or irritation\n\nSerious or Rare Side Effects:\n- Severe hypotension or cardiovascular collapse\n- Pulmonary edema\n- Significant bleeding or hemorrhage\n- Thrombocytopenia or platelet dysfunction\n- Cardiac arrhythmias\n- Anaphylactic or severe allergic reactions

Before initiating Iloprost therapy, several safety considerations should be observed.\n\nMonitor blood pressure: watch for hypotension during and after infusion.\nAssess renal function: adjust use in severe renal impairment.\nAvoid in active bleeding: increased risk due to platelet inhibition.\nUse under specialist supervision: intravenous administration requires controlled setting.\nStore at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Iloprost can interact with other medications, requiring careful management.\n\nMajor Interactions (Avoid):\n- Concomitant potent vasodilators: risk of severe hypotension.\n- Anticoagulants or antiplatelet agents: heightened bleeding tendency.\n- Other prostacyclin analogs: additive vasodilatory effects.\n\nModerate Interactions (Monitor Closely):\n- CYP450 inhibitors or inducers: may alter Iloprost plasma levels.\n- Diuretics: potential electrolyte disturbances and blood‑pressure changes.